|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/50 |
| (11) | Number of the document | 2810066 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13741424.9 |
| Date of filing the European patent application | 2013-01-23 | |
| (97) | Date of publication of the European application | 2014-12-10 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/022765 |
| Date | 2013-01-23 |
| (87) | Number | WO 2013/112601 |
| Date | 2013-08-01 |
| (30) | Number | Date | Country code |
| 201261590131 P | 2012-01-24 | US |
| (72) |
BLAKEMORE, Stephen, J., US
DI BACCO, Alessandra, M., US
MULLIGAN, George, J., US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | METHODS OF TREATMENT OF CANCER |
| METHODS OF TREATMENT OF CANCER |